The next big thing in hair growth

The hair growth market has been lacking innovation for decades. Follicopeptide® is a patented cosmetic innovation, developed through years of research, offering a new approach to hair growth.

Join the journey

The next big thing in hair growth

The hair growth market has been lacking innovation for decades. Follicopeptide® is a patented cosmetic innovation, developed through years of research, offering a new approach to hair growth.



Clinically proven efficacy,
more than 70% responders

For both men and women

Application only once daily

Strong patent

Market opportunity

Hair loss affects both men and women. Data shows that as much as 50% of all adults globally suffer from hair loss during their lifetime. Currently, there are only a few products on the market that enhances hair growth. These have limited effect, only a small percentage of those who use the product respond to the treatment, they cannot be used by women in effective doses, and cause side effects such as impotence and hair growth in unwanted places.

When it comes to products that enhances eyelashes, Follicopeptide has great potential in the global market, especially since most of the leading products on the market contain prostaglandin analogues as the active component. The EU’s Scientific Committee on Consumer Safety (SCCS) has announced its concerns about the safety of prostaglandin analogues when used in cosmetic products near the eye. The global market size for eyelash serum is estimated to 770 million US dollars and for eyebrows 289 million US dollars.

For partners & investors

Follicopeptide represents a unique opportunity in the rapidly growing hair care market. With patent and trademark protection, a strong clinical foundation and proven consumer relevance, it offers a secure and differentiated innovation.

The first cosmetic gel formulation is ready for launch in 2025, and further product opportunities are under evaluation, including applications for eyebrows, eyelashes and beard.

For partnership and investment opportunities, please contact Coegin Pharma CEO Jens Eriksson: je@coeginpharma.com

Coegin Pharma is a Swedish biotech company primarily focused on peptide-based premium products for hair growth and skin pigmentation.

Coegin Pharma’s shares are listed on NGM Nordic SME and Börse Stuttgart.

Website: coeginpharma.com

Female face with eye with long eyelashes.